Ledger.Open graph →

SEC Form D · Amendment · filed June 2, 2021

Serina Therapeutics, Inc

Offering

$76.2M

Sold

$3.7M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

HUNTSVILLE, AL

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Tacey R. Viegas · Madison, ALExec Barbara M. Fisk · Madison, ALDirector Miguel A. Loya · Houston, TXDirector Randall W. Moreadith · Huntsville, ALExec · Director James R. Hudson, Jr · Huntsville, ALDirector Michael D. Bentley · Huntsville, ALExec · Director Patrick J. Haynes, Iii · Chicago, ILDirector Alan Rutledge · San Francisco, CAExec · Director J M. Harris · Huntsville, ALExec · Director Nancy C. Floyd · Washington, Washington, D.C.Director Vincent L. Ammann · Washington, Washington, D.C.Exec · Director Roberta W. Sims · Washington, Washington, D.C.Director George P. Clancy · Washington, Washington, D.C.Exec Jeffrey Fried · Elmhurst, NYDirector Jason Carss · New York, NYExec · Director J M. Harris · Huntsville, ALExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗